A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
This executive exercised 20,407 options at $1.08 and immediately sold them at $27.28 per share.
Read the full articleYou might also wanna read
Who May Face Income Tax Scrutiny in FY 2026-27? CBDT Issues Fresh Guidelines for Complete Scrutiny
Sahi·just now
Fortune India: In Conversation
Fortune India·just now
Yacht Club de Monaco launches its Monaco Energy Boat Challenge World Series, a new global pathway for sustainable maritime innovation
Financial Post·6m ago
Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program
Financial Post·7m ago
After Expected Business Combination of Gold Resource and Goldgroup Mining, Combined Company Will Be Ineligible for Russell 2000 Comprehensive Factor Index Due to National Eligibility Requirements
Financial Post·13m ago
Exclusive-Saudi PIF set to win EU nod for Electronic Arts deal under subsidy rules, sources say
globalbankingandfinance.com·22m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.